Drug Interaction Study of MGL-3196 With Pioglitazone
Clinical trial NCT04671056 · COMPLETED
Trial details
- NCT number
- NCT04671056
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2018-12-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.